-
Information
iCFO Information Booth How can we help? -
EntrepreneurRICOVR Rapid Saliva Testing For Biomarkers
-
EntrepreneurPascal Metrics
-
EntrepreneurSovány Beverage Sovany is more than just another organic sparkling water
-
EntrepreneurTAM-C Solutions
-
EntrepreneurVitranu A drug delivery company developing a Tunable Extended-Release CapsuleTM (TERCTM) capable of long-term delivery of therapeutics via injection
-
Entrepreneur
Oberit -
EntrepreneurSimple Ideas PureE Disruptive IP Broad Spectrum Oral Anti-Pathogen Pharmaceutical
-
EntrepreneurCommerceBlitz
-
EntrepreneurSmall Eyes
-
EntrepreneurWibly Visual Learning Platform for Knowledge Networks
-
EntrepreneurIM Financial We are a technology platform focused on providing lifestyle embedded financial services for the hispannial-americans building their American dream.
Event DealConnect 360: The Ultimate Deal Room for Real Results! is over.
Join us next time to meet Gaytri Kachroo!
Join us next time to meet Gaytri Kachroo!
About Arise BioPharma
Arise BioPharma Inc. (Arise) is a wholly owned subsidiary of Peptide Account LLC. Arise holds property rights to several late stage compounds targeting neuro-degenerative illnesses. It is poised to enter a high-value Phase 2/3 clinical study in an orphan indication, namely Progressive Multifocal Leukocencephalopathy (PML) with prior clinical evidence in a proof of concept Phase 2a study and Emergency INDs.